GALLI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 600
EU - Europa 341
AS - Asia 295
SA - Sud America 64
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 21
Totale 1.372
Nazione #
US - Stati Uniti d'America 576
RU - Federazione Russa 189
SG - Singapore 149
IT - Italia 60
BR - Brasile 54
CN - Cina 40
CI - Costa d'Avorio 34
VN - Vietnam 33
BD - Bangladesh 28
IE - Irlanda 17
GB - Regno Unito 14
CA - Canada 13
FR - Francia 13
KR - Corea 11
NG - Nigeria 11
IN - India 9
SE - Svezia 8
HK - Hong Kong 6
NL - Olanda 6
AR - Argentina 5
CZ - Repubblica Ceca 5
DE - Germania 5
FI - Finlandia 5
IQ - Iraq 5
JP - Giappone 5
PL - Polonia 5
ES - Italia 4
MX - Messico 4
CH - Svizzera 3
SN - Senegal 3
HR - Croazia 2
JM - Giamaica 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AT - Austria 1
BS - Bahamas 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
MV - Maldive 1
MY - Malesia 1
PR - Porto Rico 1
RW - Ruanda 1
SV - El Salvador 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 1.351
Città #
Dallas 127
Singapore 108
Moscow 103
Santa Clara 96
Ashburn 47
San Jose 40
Abidjan 34
Los Angeles 34
Beijing 20
Dublin 17
New York 17
Chicago 16
Chandler 14
Ho Chi Minh City 14
Lauterbourg 12
Rende 12
Buffalo 11
Seoul 11
São Paulo 9
Abuja 8
Hanoi 8
Boston 7
Brooklyn 7
Civitanova Marche 6
Hong Kong 6
Montreal 6
Reggio Emilia 6
Boardman 5
Council Bluffs 5
London 5
Orem 5
Tokyo 5
Cambridge 4
Catania 4
Denver 4
Lawrence 4
San Francisco 4
Stockholm 4
Warsaw 4
Andover 3
Dakar 3
Jacksonville 3
Poplar 3
Toronto 3
Tremestieri Etneo 3
Turku 3
Atlanta 2
Bastiglia 2
Bismarck 2
Brasília 2
Chennai 2
Columbus 2
Des Moines 2
Greenville 2
Guarujá 2
Johannesburg 2
Kochi 2
Manchester 2
Milan 2
Norfolk 2
Nuremberg 2
Philadelphia 2
Port Harcourt 2
Prague 2
Rome 2
Scarsdale 2
Zagreb 2
Zurich 2
Abington 1
Ahmedabad 1
Alvorada 1
Amman 1
Amsterdam 1
Ankara 1
Arcoverde 1
Arraial do Cabo 1
Arroio Grande 1
Baghdad 1
Belo Horizonte 1
Bernareggio 1
Bexley 1
Boa Esperança 1
Bofete 1
Bologna 1
Boydton 1
Bremen 1
Budapest 1
Bắc Giang 1
Cajazeiras 1
Caracas 1
Caserta 1
Castanhal 1
Changsha 1
Cleveland 1
Colognola ai Colli 1
Copenhagen 1
Cranston 1
Crateús 1
Cuiabá 1
Cumberland 1
Totale 946
Nome #
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 158
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: A phase III, open-label, randomized trial 133
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 118
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study 117
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial 102
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 98
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 89
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 88
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 81
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 73
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis 72
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 68
Weight gain: A possible side effect of all antiretrovirals 66
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting 56
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 53
Totale 1.372
Categoria #
all - tutte 4.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.390


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217 0 3 0 0 3 0 3 1 1 0 0 6
2022/202351 4 2 2 5 5 7 0 8 14 0 1 3
2023/202422 1 8 1 0 0 3 0 1 0 0 8 0
2024/2025295 0 22 9 7 98 43 9 5 18 28 34 22
2025/2026943 45 30 147 84 152 226 66 19 32 64 49 29
2026/202726 19 7 0 0 0 0 0 0 0 0 0 0
Totale 1.372